RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,053,000 | +74.5% | 717,618 | +30.7% | 0.34% | +39.6% |
| Q2 2022 | $9,197,000 | -44.0% | 549,055 | 0.0% | 0.24% | -31.8% |
| Q1 2022 | $16,433,000 | -2.5% | 549,055 | 0.0% | 0.36% | +20.9% |
| Q4 2021 | $16,861,000 | -51.2% | 549,055 | -45.1% | 0.30% | -43.0% |
| Q1 2021 | $34,570,000 | -16.8% | 1,000,000 | 0.0% | 0.52% | -10.3% |
| Q4 2020 | $41,560,000 | -2.4% | 1,000,000 | 0.0% | 0.58% | -25.4% |
| Q3 2020 | $42,590,000 | – | 1,000,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |